Hyperprolactinemia-induced acute ischemic stroke - 03/08/23

, Danielle Dressler, MD a, b
, Sara Johnson, MD a
, Katerina Antonishina, BS c
, Melody Suh, BS c 
Abstract |
Strokes are the fifth leading cause of death in the United States with almost 800,000 patients seeking emergency care each year—most of whom are seen for ischemic strokes. Acute ischemic strokes (AIS) can be caused by emboli in diseases such as atrial fibrillation as well as thrombus formation in the form of platelet deposition in patients with atherosclerotic disease. Platelet activation by immunomodulators including thromboxane A2 (TXA2), serotonin, and thrombin have been extensively delineated; however, the activation by hormones such as prolactin has only recently been revealed. We present a case of a 25-year-old male with a history of pituitary microadenoma and hyperprolactinemia who presented with an acute ischemic stroke in the setting of medication non-compliance. To our knowledge, this is the first known case of AIS in a patient with known hyperprolactinemia who presented with a stroke due to be medication non-compliance.
Le texte complet de cet article est disponible en PDF.Keywords : Acute ischemic stroke, Hyperprolactinemia, Pituitary adenoma, Neurology
Plan
Vol 71
P. 249.e1-249.e2 - septembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
